Onderzoeker
Asif Hameed Khan
- Disciplines:Dermatologie
Affiliaties
- Vakgroep Hoofd en Huid (Departement)
Lid
Vanaf1 okt 2018 → 25 sep 2022 - Vakgroep Neus-, Keel- en Oorheelkunde (Departement)
Lid
Vanaf18 mei 2017 → 30 sep 2018
Publicaties
1 - 10 van 90
- Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps(2022)
Auteurs: Joaquim Mullol, Claus Bachert, Nikhil Amin, Martin Desrosiers, Peter W Hellings, Joseph K Han, Roger Jankowski, Jan Vodicka, Nadia Daizadeh, Asif Hameed Khan, et al.
Pagina's: 1086 - 1095.e5 - Dupilumab improves health related quality of life : results from the phase 3 SINUS studies(2022)
Auteurs: Stella E Lee, Claire Hopkins, Joaquim Mullol, Jérôme Msihid, Isabelle Guillemin, Nikhil Amin, Leda P Mannent, Yongtao Li, Shahid Siddiqui, Chien Chia Chuang, et al.
Pagina's: 2211 - 2221 - Development of Sinonasal Outcome Test (SNOT-22) domains in chronic rhinosinusitis with nasal polyps(2022)
Auteurs: Asif Hameed Khan, Matthew Reaney, Isabelle Guillemin, Lauren Nelson, Shanshan Qin, Siddhesh Kamat, Leda Mannent, Nikhil Amin, Diane Whalley, Claire Hopkins
Pagina's: 933 - 941 - Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD) : measurement properties of novel patient-reported symptom measures(2022)
Auteurs: Adam Gater, Linda Nelsen, Cheryl D Coon, Sonya Eremenco, Sean OU+2019Quinn, Asif Hameed Khan, Laurent Eckert, Hannah Staunton, Nicola Bonner, Rebecca Hall, et al.
Pagina's: 1249 - 1259 - Response to the correspondence : 'Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma'(2022)
Auteurs: Eric D Bateman, Asif Hameed Khan, Yingxin Xu, Patricia Guyot, Paul Rowe, Heather Burnett, Jerome Msihid, David Weinreich, Ian Pavord
- Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases(2022)
Auteurs: G Walter Canonica, Arnaud Bourdin, Anju T Peters, Martin Desrosiers, Claus Bachert, Stephan Weidinger, Eric L Simpson, Nadia Daizadeh, Zhen Chen, Siddesh Kamat, et al.
Pagina's: 1515 - 1526 - Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps(2022)
Auteurs: Peter Hellings, Anju T Peters, Adam M Chaker, Enrico Heffler, Haixin Zhang, Amy Praestgaard, Scott Nash, Asif Hameed Khan, Shahid Siddiqui, Juby A Jacob-Nara, et al.
Pagina's: 958 - 962 - Dupilumab achieves durable reduction in severity of symptoms rated most important by patients with chronic rhinosinusitis with nasal polyps(2022)Volume: 149
Auteurs: Claire Hopkins, Stella Lee, Wytske Fokkens, Eugene Chang, Jérôme Msihid, Asif Hameed Khan, Urvi Mujumdar, Siddhesh Kamat, Scott Nash, Shahid Siddiqui, et al.
Pagina's: AB142 - AB142 - Evaluating treatment responses of dupilumab versus omalizumab in type 2 patients : the EVEREST trial(2022)Volume: 149
Auteurs: Lucia de Prado Gomez, Asif Hameed Khan, Anju Peters, Claus Bachert, Martin Wagenmann, Enrico Heffler, Claire Hopkins, Peter Hellings, Mei Zhang, Jun Xing, et al.
Pagina's: AB49 - AB49 - Chronic rhinosinusitis : natural history, impact on health-related quality of life, and patient perspectives(2022)
Auteurs: Asif Hameed Khan